nsnps	PP.H0.abf	PP.H1.abf	PP.H2.abf	PP.H3.abf	PP.H4.abf	traits
1175	3.07163486918659e-126	1.14450047749383e-125	0.0681145675803966	0.253118179454765	0.67876725296486	Lung cancer ILCCO/UKB & GLA:LA / D6D (CHARGE)
1175	2.19276745704757e-13	8.17031811560487e-13	0.140812679934454	0.524337470545276	0.334849849519232	Lung cancer ILCCO/UKB & GLA:LA / D6D (Framingham)
1175	1.06204603705053e-14	3.95721577690855e-14	0.211063596991813	0.786426860569067	0.00250954243906718	Lung cancer ILCCO/UKB & FADS2 expression in adipose subcutaneous in GTEx (median MAC=202, min=10, max=580)
1175	1.01454885106064e-10	3.78023981993413e-10	0.211042397292434	0.786347769555347	0.00260983267274001	Lung cancer ILCCO/UKB & FADS2 expression in adipose visceral omentum in GTEx (median MAC=170, min=10, max=468)
1175	0.178222424011725	0.664062162556266	0.0166038628777869	0.0617871727847059	0.0793243777695157	Lung cancer ILCCO/UKB & FADS2 expression in liver in GTEx (median MAC=74, min=5, max=208)
1175	4.24224646398385e-21	1.58067391159737e-20	0.211056855980616	0.786401711466597	0.00254143255278663	Lung cancer ILCCO/UKB & FADS2 expression in lung in GTEx (median MAC=182, min=11, max=510)
1175	9.9850928844305e-250	3.72047592267279e-249	0.21103011410045	0.786301943899697	0.00266794199984547	Lung cancer ILCCO/UKB & FADS2 expression in whole blood in GTEx (median MAC=236, min=14, max=662)
1175	0	0	0.211030114262559	0.786301944504793	0.00266794123291833	Lung cancer ILCCO/UKB & FADS2 expression in blood in eQTLGen (Median N=31024, min=8242, max=31470)
